Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma. | Cancer Cell Int | 2022 | 35135529 | PubTator, text mining | PubMed |
| Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice. | J Med Chem | 2022 | 35133171 | PubTator, text mining | PubMed |
| Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19. | Heliyon | 2022 | 35128114 | PubTator, text mining | PubMed |
| Anesthetic management of a child with Cornelia de Lange Syndrome undergoing open heart surgery: A case report. | World J Cardiol | 2022 | 35126872 | PubTator, text mining | PubMed |
| Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1. | Oxid Med Cell Longev | 2022 | 35126818 | PubTator, text mining | PubMed |
| Detection of germline mosaicism in fathers of children with intellectual disability syndromes caused by de novo variants. | Mol Genet Genomic Med | 2022 | 35118825 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. | World J Gastroenterol | 2022 | 35110952 | PubTator, text mining | PubMed |
| Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation. | Sci Rep | 2022 | 35110603 | PubTator, text mining | PubMed |
| Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates. | Sci Rep | 2022 | 35110592 | PubTator, text mining | PubMed |
| Prognostic Signatures and Therapeutic Value Based on the Notch Pathway in Renal Clear Cell Carcinoma. | Oxid Med Cell Longev | 2022 | 35096263 | PubTator, text mining | PubMed |
| Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. | J Cancer Res Clin Oncol | 2022 | 35094142 | PubTator, text mining | PubMed |
| Splice variants denote differences between a cancer stem cell side population of EWSR1‑ERG‑based Ewing sarcoma cells, its main population and EWSR1‑FLI‑based cells. | Int J Mol Med | 2022 | 35088879 | PubTator, text mining | PubMed |
| Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer. | J Oncol | 2022 | 35087589 | PubTator, text mining | PubMed |
| HDAC inhibitor cowanin extracted from G. fusca induces apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathways in Jurkat cells. | Biomed Pharmacother | 2022 | 35078092 | PubTator, text mining | PubMed |
| Balancing Histone Deacetylase (HDAC) Inhibition and Drug-likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors. | ChemMedChem | 2022 | 35073610 | PubTator, text mining | PubMed |
| Histone deacetylase HDAC2 regulates microRNA-125a expression in neuroblastoma. | Brain Behav | 2022 | 35060363 | PubTator, text mining | PubMed |
| Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis. | Pharmaceuticals (Basel) | 2022 | 35056137 | PubTator, text mining | PubMed |
| HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma. | Int J Mol Sci | 2022 | 35055045 | PubTator, text mining | PubMed |
| Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology. | Cells | 2022 | 35053315 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension. | Biomedicines | 2022 | 35052850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=42